CymaBay Therapeutics Deal May Not Be Needle Moving For $100B Valued Gilead, But Acquisition Is Reasonably Priced: Analyst
Stocks in this Quantisnow insightHealth Care
Quantisnow market dataNASDAQ
CBAY
CymaBay Therapeutics Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Get push alerts for CBAY
Full CBAY profile on Quantisnow Follow CBAY and get a push notification the moment its next story breaks.